American Journal of Clinical Dermatology

, Volume 6, Issue 2, pp 79–87

Cutaneous Adverse Reactions Following Anti-Infective Vaccinations

  • Arjen F. Nikkels
  • Nazli Nikkels-Tassoudji
  • Gerald E. Piérard
Leading Article

Abstract

Although widely administered, anti-infective vaccinations are rarely responsible for cutaneous adverse effects. In this context, hepatitis B and bacillus Calmette-Guerin vaccines are the most frequently incriminated products. Cutaneous adverse effects are less frequently encountered following administration of vaccines against varicella, diphtheria/tetanus/pertussis (primary and booster doses), measles, poliomyelitis, rubella, pneumococcus, tick-borne encephalitis, smallpox, Meningococcus and influenza. The adverse effects can occur at the site of or at a distance from the injection. The patho-mechanisms of local adverse cutaneous reactions include predominantly nonspecific lymphoid or granulomatous reactions. Allergic reactions to the vaccine strain, adjuvants, conservatives or other components are less frequently involved in local vaccine adverse effects. Systemic reactions are mainly mediated by immediate type or immune complex-related allergic reactions to toxoid-, ovalbumin-, gelatin- or pneumococcal-containing vaccines. Systemic reactions are sometimes related to a specific vaccine strain. Other cutaneous reactions may also occur through unknown patho-mechanisms. No vaccine type or strain is specifically associated with a particular type of cutaneous adverse effect.

This article presents seven case reports of cutaneous adverse effects following anti-infective vaccination then reviews the relevant literature on this subject.

References

  1. 1.
    Ponvert C, Scheinmann P. Vaccine allergy and pseudo-allergy. Eur J Dermatol. 2003; 13: 10–5PubMedGoogle Scholar
  2. 2.
    Ovetchkine P. Effets secondaires des vaccinations. Arch Pediatr. 2001; 8: 316–20PubMedCrossRefGoogle Scholar
  3. 3.
    Usman A, Kimyai-Asadi A, Stiller MJ, et al. Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol. 2001; 18: 123–6PubMedCrossRefGoogle Scholar
  4. 4.
    Schupp P, Vente C. Lichen planus following hepatitis B vaccination. Int J Dermalot. 1999; 38: 799–800Google Scholar
  5. 5.
    Ferrando MF, Doutre MS, Beylot-Barry M, et al. Lichen planus following hepatitis B vaccination [letter]. Br J Dermatol. 1998; 139: 350PubMedCrossRefGoogle Scholar
  6. 6.
    Aubin F, Angonin R, Humbert P, et al. Lichen planus following hepatitis B vaccination. Arch Dermatol. 1994; 130: 1329–30PubMedCrossRefGoogle Scholar
  7. 7.
    Ciaccio E, Ciaccio M, Rebora A. Lichen planus following HBV vaccination: a coincidence? [letter]. Br J Dermatol. 1990; 122: 424PubMedCrossRefGoogle Scholar
  8. 8.
    Trevisan G, Stinco G. Lichen ruber planus following HBV vaccination [letter]. Acta Derm Venereol. 1993; 73: 73PubMedGoogle Scholar
  9. 9.
    Trevisan G, Stinco G. HBV vaccination and lichen planus. G Ital Dermatol Venereol. 1993; 128: 545–8Google Scholar
  10. 10.
    Lefort A, Dachary D, Vergier B, et al. Lichen plan et vaccination anti hépatite B. Ann Dermatol Venereol 1995; 122: 701–3PubMedGoogle Scholar
  11. 11.
    Saywell CA, Wittal RA, Kossard S. Lichenoid reaction to hepatitis B vaccination. Aust J Dermatol. 1997; 38: 152–4CrossRefGoogle Scholar
  12. 12.
    Tessad G, Barba A, Schena D. Lichen ruber planus following the administration of human anti-hepatitis B virus immunoglobulins. Acta Derm Venereol. 1996; 76: 1564–74Google Scholar
  13. 13.
    Rybojad M, Moraillon I, Laglenne S, et al. Lichen plan de l’enfant: 12 cas. Ann Dermatol Venereol. 1998; 125: 679–81PubMedGoogle Scholar
  14. 14.
    Dalton SJ, Haeney MR, Patel L, et al. Exacerbation of atopic dermatitis after bacillus Calmette-Guerin vaccination. J R Soc Med. 1998; 91: 133–4PubMedGoogle Scholar
  15. 15.
    Kumagai T, Yamanaka T, Wataya Y, et al. A strong association between HLA-DR9 and gelatin allergy in the Japanese population. Vaccine. 2001; 19: 3273–6PubMedCrossRefGoogle Scholar
  16. 16.
    Elgart GW, Hanly A, Busso M, et al. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy. J Am Acad Dermatol; 1999; 40: 315–7PubMedCrossRefGoogle Scholar
  17. 17.
    Hazelrigg DE. Basal cell epithelioma in a vaccination scar. Int J Dermatol. 1978; 17: 723–5PubMedGoogle Scholar
  18. 18.
    Panizzon R. Basal cell epithelioma in a BCG vaccination scar [letter]. Arch Dermatol. 1980; 116: 381PubMedCrossRefGoogle Scholar
  19. 19.
    Lanzafame S, Micali G. Cutaneous lymphoid hyperplasie (pseudolymphoma) secondary to vaccination. Pathologica. 1993; 85: 555–61PubMedGoogle Scholar
  20. 20.
    Cotterill JA, Shapiro H. Dermatomyositis after immunisation. Lancet. 1978; II: 1158–9CrossRefGoogle Scholar
  21. 21.
    Ehrengut W. Dermatomyositis and vaccination. Lancet. 1978; I: 1040–1CrossRefGoogle Scholar
  22. 22.
    Tay YK. Gianotti-Crosti syndrome following immunization [letter]. Pediatr Dermatol. 2001; 18: 262PubMedGoogle Scholar
  23. 23.
    Lugosi L. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology: a review. Tuber Lung Dis. 1992; 73: 252–61PubMedCrossRefGoogle Scholar
  24. 24.
    Antaya RJ, Gardner ES, Bettencourt MS, et al. Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol. 2001; 18: 205–9PubMedCrossRefGoogle Scholar
  25. 25.
    Grange JM. Complications of bacille Calmette-Guerin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health. 1998; 1: 84–8PubMedGoogle Scholar
  26. 26.
    Verbov J. Local skin complications of BCG vaccination. Practitioner. 1984; 228: 1069–71PubMedGoogle Scholar
  27. 27.
    Murphy PM, Mayers DL, Brock NF, et al. Cure of bacille Calmette-Guérin vaccination abscesses with erythromycin. Rev Infect Dis. 1989; 11: 335–7PubMedCrossRefGoogle Scholar
  28. 28.
    Raton JA, Pocheville I, Vincente JM, et al. Disseminated bacillus Calmette-Guérin infection in an HIV-infected child: a case with cutaneous lesions. Pediatr Dermatol. 1997; 14: 365–8PubMedCrossRefGoogle Scholar
  29. 29.
    Talbot EA, Perkins MD, Silva SFM, et al. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997; 24: 1139–46PubMedCrossRefGoogle Scholar
  30. 30.
    McKenzie RH, Roux P. Disseminated BCG infection following bone marrow transplantation for X-linked severe combined immunodeficiency. Pediatr Dermatol. 2000; 17: 208–12PubMedCrossRefGoogle Scholar
  31. 31.
    Gonzales B, Moreno S, Burdach R, et al. Clinical presentations of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J. 1989; 8: 201–6Google Scholar
  32. 32.
    Fang JW, Ko BM, Wilson JA. BCG vaccination scars: incidence and acceptance amongst British high-school children. Child Care Health Dev. 1993; 19: 37–43PubMedCrossRefGoogle Scholar
  33. 33.
    Lawrence CM, Summerly ME. Keloid formation after BCG vaccination. Practitioner. 1982; 226: 326–8PubMedGoogle Scholar
  34. 34.
    Magnon R, DeVillez RL. Disseminated cutaneous granulomas from BCG therapy. Arch Dermatol. 1980; 116: 355PubMedCrossRefGoogle Scholar
  35. 35.
    Lewis K, Jordan SC, Cherry JD, et al. Petechiae and urticaria after DTP vaccination: detection of circulating immune complexes containing vaccine-specific antigens. J Pediatr. 1986; 109: 1009–12PubMedCrossRefGoogle Scholar
  36. 36.
    Dogliotti M. Erythema multiforme: an unusual reaction to BCG vaccination. South Afr Med J. 1980; 57: 332–4Google Scholar
  37. 37.
    Tschen EH, Jessen RT, Robertson G, et al. Erythema multiforme as a complication of BCG scarification technique. Arch Dermatol. 1979; 115: 614–5PubMedCrossRefGoogle Scholar
  38. 38.
    Cheson B. BCG therapy and urticaria. Ann Intern Med. 1975; 82: 738–9Google Scholar
  39. 39.
    Fauquert JL, Tridon A, Labbé A, et al. Réaction anaphylactoide post-BCG: le rôle du dextran?. Rev Fr Allergol Immunol Clin. 2001; 41: 412–4Google Scholar
  40. 40.
    Balagon MV, Tan PL, Prestidge R, et al. Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open-label trial. Clin Exp Dermatol. 2001; 26: 233–41PubMedCrossRefGoogle Scholar
  41. 41.
    Park YM, Kang H, Cho SH, et al. Lichen scrofulosorum-like eruption localized to multipuncture BCG vaccination site. J Am Acad Dermatol. 1999; 41: 262–4PubMedCrossRefGoogle Scholar
  42. 42.
    Dostrovsky A, Sagher F. Dermatologic complications of BCG vacinnation. Br J Dermatoll. 1963; 75: 181–92CrossRefGoogle Scholar
  43. 43.
    Stewart EJ, James MP. Lupus vulgaris-like reaction following BCG vaccination. Clin Exp Dermatol. 1996; 21: 232–4PubMedCrossRefGoogle Scholar
  44. 44.
    Mori T, Yamauchi Y, Shiozawa K. Lymph node swelling due to bacille Calmette-Guerin vaccination with multipuncture method. Tuber Lung Dis. 1996; 77: 269–73PubMedCrossRefGoogle Scholar
  45. 45.
    Radeff B, Harms M. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) following BCG vaccination. Acta Dermatol Venereol. 1986; 66: 357–8Google Scholar
  46. 46.
    Kothad SS. Aetiopathogenesis of Takayasu’s arteritis and BCG vaccination: the missing link?. Med Hypotheses. 1995; 45: 227–30CrossRefGoogle Scholar
  47. 47.
    Lee SM, Hann SK, Chun SI, et al. An unusual form of skin tuberculosis following BCG vaccination. J Dermatol. 1994; 21: 106–10PubMedGoogle Scholar
  48. 48.
    Houcke-Bruge C, Delaporte E, Catteau B, et al. Granulome annulaire après vaccination par le BCG vaccination. Ann Dermatol Venereol. 2001; 128: 541–4PubMedGoogle Scholar
  49. 49.
    Rennels MR, Deloria MA, Pichichero ME, et al. Lack of consistent relationship between quantity of aluminium in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine. 2002; 20: 544–7CrossRefGoogle Scholar
  50. 50.
    Pembroke AC, Marten RH. Unusual cutaneous reactions following diphtheria and tetanus immunization. Clin Exp Dermatol. 1979; 4: 345–8PubMedCrossRefGoogle Scholar
  51. 51.
    Blennow M, Granstrom M, Strandell A. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine. 1994; 12: 427–30PubMedCrossRefGoogle Scholar
  52. 52.
    Ponvert C, Scheinmann P, Karila C, et al. L’allergie aux vaccins associés chez l’enfant: une étude de 30 cas fondée sur les tests cutanés à lecture immédiate, semi retardée, et retardée, sur les dosages des anticoprs spécifiques et sur l’injection de rappel. Rev Fr Allerg Immunol Clin. 2001; 41: 701–11Google Scholar
  53. 53.
    Poley GE, Slater JE. Drug and vaccine allergy. Immunol Allergy Clin N Am. 1999; 19: 409–22CrossRefGoogle Scholar
  54. 54.
    Johnson C, Walls RS, Ruwoldt A. Delayed type hypersensitivity to tetanus toxoid in man. In vivo and in vitro studies. Pathology. 1983; 15: 369–72PubMedCrossRefGoogle Scholar
  55. 55.
    Griffith RD, Miller III OF. Erythema multiforme following diphtheria and tetanus toxoid vaccination. J Am Acad Dermatol. 1988; 19: 758–9PubMedCrossRefGoogle Scholar
  56. 56.
    Baraff LJ, Manclark CR, Cherry JD, et al. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J; 1989; 8: 502–7PubMedCrossRefGoogle Scholar
  57. 57.
    Fawcett HA, Smith NP. Injection-site granuloma due to aluminum. Arch Dermatol. 1984; 120: 1318–22PubMedCrossRefGoogle Scholar
  58. 58.
    Slater DN, Underwood JCE, Durrant TE, et al. Aluminium hydroxide granulomas: light and electron microscopy studies and X-ray microanalysis. Br J Dermatol. 1982; 107: 103–8PubMedCrossRefGoogle Scholar
  59. 59.
    Nagore E, Martinez-Escribano JA, Tata A, et al. Subcutaneous nodules following treatments with aluminium-containing allergen extracts. Fur J Dermatol. 2001; 11: 138–40Google Scholar
  60. 60.
    Akosa AB, Ali MH Khoo CT, et al. Angiolymphoid hyperplasia with eosinophilia associated with tetanus toxoid vaccination. Histopathology. 1990; 16: 589–93PubMedCrossRefGoogle Scholar
  61. 61.
    Baykal C, Okan G, Sarica R. Childhood buttons pemphigoid developed after the first vaccination. J Am Acad Dermatol. 2001; 44 Suppl. 2: 348–50PubMedCrossRefGoogle Scholar
  62. 62.
    Venning VA, Wojnarowska F. Induced buttons pemphigoid. Br J Dermatol. 1995; 132: 831–2PubMedCrossRefGoogle Scholar
  63. 63.
    Fournier B, Descamps V, Bouscarat F, et al. Buttons pemphigoid induced by vaccination. Br J Dermatol. 1996; 135: 144–61CrossRefGoogle Scholar
  64. 64.
    Bellaney GJ, Rycroft RJ. Pemphigus vulgaris following a hyperimmune response to typhoid booster. Clin Exp Dermatol. 1996; 21: 434–6PubMedCrossRefGoogle Scholar
  65. 65.
    Leung AKC. Anaphylaxis to DPT vaccine [letter]. J R Soc Med. 1985; 78: 175PubMedGoogle Scholar
  66. 66.
    Piletta PA, Pasche-Koo F, Samat JH, et al. Immediate local reaction to tetanus toxoid booster. Allergy. 1997; 52: 676–7PubMedCrossRefGoogle Scholar
  67. 67.
    Kwittken P, Rosen S, Sweinberg S. MMR vaccine and neomycin allergy. Am J Dis Child. 1993; 147: 128–9PubMedGoogle Scholar
  68. 68.
    Beck S, Williams LW, Shirrell MA, et al. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Pediatrics. 1991; 88: 913–7PubMedGoogle Scholar
  69. 69.
    Fasano MB, Wood RA, Cooke SK, et al. Egg hypersensitivity and adverse reactions to measles, mumps and rubella vaccine. J Pediatr. 1992; 120: 878–81PubMedCrossRefGoogle Scholar
  70. 70.
    Vourga V, Tapratzi P, Panayatopoulou K. Measles-mumps-rubella vaccine (MMR) in egg-allergic children [letter]. Allergy. 1997; 52: 96Google Scholar
  71. 71.
    Aukrust L, Almeland TL, Refsum D, et al. Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Allergy. 1980; 35: 581–7PubMedCrossRefGoogle Scholar
  72. 72.
    Buntain WL, Missall SR. Local subcutaneous atrophy following measles, mumps, and rubella vaccination [letter]. Am J Dis Child. 1976; 130: 335PubMedGoogle Scholar
  73. 73.
    Aickin R, Hill D, Kemp A. Measles immunisation in children with allergy to egg. BMJ. 1994; 409: 223–5CrossRefGoogle Scholar
  74. 74.
    Bellanti JA, Fishman HJ, Wientzen RL. Adverse reactions to vaccines. Immunol Allergy Clin N Am. 1987; 7: 423–45Google Scholar
  75. 75.
    Ponvert C, Ardelean-Jaby D, Colin-Gorski AM, et al. Anaphylaxis to the 23-valent pneumococcal vaccine in children: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine. 2001; 19: 4588–91PubMedCrossRefGoogle Scholar
  76. 76.
    Maddox PR, Motley RJ. Sweet’s syndrome: a severe complication of pneumococcal vaccination following emergency splenectomy. Br J Surg. 1990; 77: 809–10PubMedCrossRefGoogle Scholar
  77. 77.
    Furth SL, Fivush BA. Varicella vaccination in pediatric kidney transplant candidates. Pediatr Transplant. 2002; 6: 97–100PubMedCrossRefGoogle Scholar
  78. 78.
    Kumagai T, Yamanaka T, Wataya Y, et al. Gelatin-specific Immoral and cellular immune responses in children with immediate and non-immediate type reactions to live measles, mumps, rubella and varicella vaccines. J Allergy Clin Immunol. 1997; 30: 1430–5Google Scholar
  79. 79.
    Anonymous. Varicella vaccine. Med Lett Drugs Ther. 1995; 37: 55–7Google Scholar
  80. 80.
    LaRussa P, Steinberg SP, Shapiro E, et al. Viral strain identification in varicella vaccinees with disseminated rashes. Pediatr Infect Dis. 2000; 19: 1037–9CrossRefGoogle Scholar
  81. 81.
    Liang MG, Heidelberg KA, Jacobson RM, et al. Herpes zoster after varicella immunization. J Am Acad Dermatol. 1998; 38: 761–3PubMedCrossRefGoogle Scholar
  82. 82.
    Kamiya H, Ito M. Update on varicella vaccine. Curr Opin Pediatr. 1999; 11: 3–8PubMedCrossRefGoogle Scholar
  83. 83.
    Gerecitano J, Friedman-Kien A, Chazen GD. Allergic reaction to varicella vaccine. Ann Intern Med. 1997; 126: 833–4PubMedGoogle Scholar
  84. 84.
    McMahon BJ, Helminiak C, Wainwright RB, et al. Frequency of adverse reactions to hepatitis B vaccine in 43618 persons. Am J Med. 1992; 91: 254–5CrossRefGoogle Scholar
  85. 85.
    Wolf F, Grezard P, Berard F, et al. Generalized granuloma annulare and hepatitis B vaccination. Fur J Dermatol. 1998; 8: 435–6Google Scholar
  86. 86.
    Schmutz JL, Posth M, Granel F, et al. Localized scleroderma after hepatitis B vaccination [in French: letter]. Presse Med. 2000; 29 (19): 1046PubMedGoogle Scholar
  87. 87.
    Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ. 1990; 301: 345PubMedCrossRefGoogle Scholar
  88. 88.
    De Keyser F, Naeyaert JM, Hindryckx P, et al. Immune-mediated pathology following hepatitis B vaccination: two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol. 2000; 18: 8–15Google Scholar
  89. 89.
    Barbaud A, Trechot P, Reichert-Penetrat S, et al. Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol. 1998; 139: 925–6PubMedCrossRefGoogle Scholar
  90. 90.
    Lohiya G. Asthma and urticaria after hepatitis B vaccination [letter]. West J Med. 1987; 147: 341PubMedGoogle Scholar
  91. 91.
    Di Lernia V, Lo Scocco G, Bisighini G. Erythema multiforme following hepatitis B vaccine. Pediatr Dermatol. 1994; 11: 363–4PubMedCrossRefGoogle Scholar
  92. 92.
    Wakeel RA, White MI. Erythema multiforme associated with hepatitis B vaccine. Br J Dermatol. 1992; 126: 94–5PubMedCrossRefGoogle Scholar
  93. 93.
    Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine. N Eng J Med. 1989; 321: 1198–9CrossRefGoogle Scholar
  94. 94.
    Castresana-Ilsa CJ, Herrera-Martinez G, Vega-Molina J. Erythema nodosum and Takayashu’s arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol. 1993; 20: 1417–8Google Scholar
  95. 95.
    Rabaud C, Barbaud A, Trechot P. First case of erythermalgia related to hepatitis B vaccination. J Rheumatol. 1999; 26: 233–4PubMedGoogle Scholar
  96. 96.
    Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA. 1997; 278: 1176–8PubMedCrossRefGoogle Scholar
  97. 97.
    Sepkowitz S. Hair loss after immunization. JAMA. 1998; 279: 117–8PubMedCrossRefGoogle Scholar
  98. 98.
    Niu MT, Davis DM, Ellenberg S. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 1996; 15: 771–6PubMedCrossRefGoogle Scholar
  99. 99.
    Hurwitz S. Clinical pediatric dermatology. Philadelphia (PA): WB Saunders Co, 1981: 366Google Scholar
  100. 100.
    Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995; 70: 628–33PubMedCrossRefGoogle Scholar
  101. 101.
    Finielz P, Lam-Kam-Sang LF, Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant. 1998; 13: 2420–1PubMedCrossRefGoogle Scholar
  102. 102.
    Le Hello C, Cohen P, Bousser MG, et al. Suspected hepatitis B vaccination related vasculitis. J Rheumatol. 1999; 26: 191–4PubMedGoogle Scholar
  103. 103.
    Bani-Sadr F, Gueit I, Humbert G. Vasculitis related to hepatitis A vaccination. Clin Infect Dis. 1996; 22: 596PubMedCrossRefGoogle Scholar
  104. 104.
    Poulton JK, Kauffman CL, Lutz LL, et al. Solitary mastocytoma arising at a hepatitis B vaccination site. Cutis. 1999; 63: 37–40PubMedGoogle Scholar
  105. 105.
    Daoud MS, Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Am Acad Dermatol. 1997; 36: 779–80PubMedCrossRefGoogle Scholar
  106. 106.
    Skowron F, Grezard P, Berard F, et al. Persistent nodules at sites of hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis. 1998; 39: 135–6PubMedCrossRefGoogle Scholar
  107. 107.
    Naleway AL, Belongia EA, Greenlee RT, et al. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med. 2003; 139: 1–7PubMedGoogle Scholar
  108. 108.
    Anonymous. Smallpox vaccination and eczema. Med J Aust. 1976; 2: 620–1Google Scholar
  109. 109.
    Mintz L. Recurrent herpes simplex infection at a smallpox vaccination site. JAMA. 1982; 247: 2704–5PubMedCrossRefGoogle Scholar
  110. 110.
    Slater DN, Parsons MA, Fussey IV. Malignant fibrous histiocytoma arising in a smallpox vaccination scar. Br J Dermatol. 1981; 105: 215–7PubMedCrossRefGoogle Scholar
  111. 111.
    Rich JD, Shesol BF, Home III DW. Basal cell carcinoma arising in a smallpox vaccination site. J Clin Pathol. 1980; 33: 134–5PubMedCrossRefGoogle Scholar
  112. 112.
    Castrow FF, Williams TE. Basal-cell epithelioma occurring in a smallpox vaccination scar. J Dermatol Surg. 1976; 2: 151–2PubMedGoogle Scholar
  113. 113.
    Mignogna MD, Muzio LL, Ruocco E. Pemphigus induction by influenza vaccination [letter]. Int J Dermatol. 2000; 39: 800PubMedGoogle Scholar
  114. 114.
    Downs AM, Lear JT, Bower CP, et al. Does influenza vaccination induce buttons pemphigoid?: a report of four cases [letter]. Br J Dermatol. 1998; 138: 363PubMedCrossRefGoogle Scholar
  115. 115.
    Schmutz JL, Barbaud A, Trechot P. Does influenza vaccination induce buttons pemphigoid? [in French]. Ann Derm Venereol. 1999; 126 (10): 765Google Scholar
  116. 116.
    Fournier B, Descamps V, Bouscarat F, et al. Buttons pemphigoid induced by vaccination. Br J Dermatol. 1996; 135: 153–4PubMedCrossRefGoogle Scholar
  117. 117.
    Cambiaghi S, Scarabelli G, Pistritto G, et al. Gianotti-Crosti syndrome in an adult after influenza virus vaccination. Dermatology. 1995; 191: 340–1PubMedCrossRefGoogle Scholar
  118. 118.
    Confino I, Passwell JH, Padeh S. Erythromelalgia following influenza vaccine in a child. Clin Exp Rheumatol. 1997; 15: 111–3PubMedGoogle Scholar
  119. 119.
    Gavaghan T, Webber CK. Severe systemic vasculitic syndrome post influenza vaccination [letter]. Aust N Z J Med. 1993; 23: 220PubMedCrossRefGoogle Scholar
  120. 120.
    Kelsall JT, Chalmers A, Sherlock CH, et al. Microscopic polyangiitis after influenza vaccination. J Rheumatol. 1997; 24: 1198–202PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Arjen F. Nikkels
    • 1
    • 2
  • Nazli Nikkels-Tassoudji
    • 2
  • Gerald E. Piérard
    • 1
  1. 1.Department of DermatopathologyUniversity Hospital of Li`egeLiègeBelgium
  2. 2.Dermatology DivisionSankt Josef KlinikSankt VithBelgium

Personalised recommendations